Dyne Therapeutics (NYSE:DYN) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Dyne Therapeutics (NYSE:DYNGet Rating) in a research note issued to investors on Thursday. The firm set a “hold” rating on the stock.

Dyne Therapeutics Trading Down 6.4 %

NYSE DYN opened at $12.63 on Thursday. Dyne Therapeutics has a 12-month low of $4.30 and a 12-month high of $15.63.

Further Reading

Receive News & Ratings for Dyne Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyne Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.